Omega Healthcare Investors (OHI) Lifted to Outperform at Wells Fargo & Co

Omega Healthcare Investors (NYSE:OHI) was upgraded by investment analysts at Wells Fargo & Co from a “market perform” rating to an “outperform” rating in a research note issued on Thursday, Marketbeat Ratings reports.

OHI has been the topic of a number of other research reports. TheStreet lowered Omega Healthcare Investors from a “b-” rating to a “c” rating in a research note on Monday, October 30th. Capital One Financial initiated coverage on Omega Healthcare Investors in a research note on Monday, October 23rd. They issued an “equal weight” rating and a $34.00 target price on the stock. Vetr lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 target price on the stock. in a research note on Monday, October 30th. Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Finally, Hilliard Lyons lowered Omega Healthcare Investors to a “buy” rating in a research note on Wednesday, November 1st. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $31.57.

Shares of Omega Healthcare Investors (OHI) traded up $0.38 during trading hours on Thursday, hitting $25.99. The stock had a trading volume of 3,816,206 shares, compared to its average volume of 2,570,739. The stock has a market cap of $5,230.00, a price-to-earnings ratio of 56.59, a price-to-earnings-growth ratio of 2.78 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40. Omega Healthcare Investors has a fifty-two week low of $24.90 and a fifty-two week high of $35.14.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Tuesday, February 13th. The real estate investment trust reported $0.31 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by ($0.18). Omega Healthcare Investors had a return on equity of 2.44% and a net margin of 11.06%. The firm had revenue of $221.21 million for the quarter, compared to analysts’ expectations of $219.07 million. sell-side analysts expect that Omega Healthcare Investors will post 3.23 EPS for the current year.

In other Omega Healthcare Investors news, Director Bernard J. Korman purchased 100,000 shares of the business’s stock in a transaction on Friday, December 22nd. The stock was bought at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the acquisition, the director now owns 896,895 shares of the company’s stock, valued at approximately $24,117,506.55. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.54% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. raised its holdings in Omega Healthcare Investors by 2.1% in the 4th quarter. BlackRock Inc. now owns 21,258,742 shares of the real estate investment trust’s stock valued at $585,466,000 after acquiring an additional 438,005 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Omega Healthcare Investors by 0.9% in the 3rd quarter. Principal Financial Group Inc. now owns 5,554,583 shares of the real estate investment trust’s stock valued at $177,245,000 after acquiring an additional 50,760 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Omega Healthcare Investors by 11.8% in the 4th quarter. Bank of New York Mellon Corp now owns 4,408,364 shares of the real estate investment trust’s stock valued at $121,406,000 after acquiring an additional 466,377 shares during the last quarter. LSV Asset Management raised its holdings in Omega Healthcare Investors by 106.1% in the 4th quarter. LSV Asset Management now owns 4,006,633 shares of the real estate investment trust’s stock valued at $110,342,000 after acquiring an additional 2,062,428 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in Omega Healthcare Investors by 14,906.5% in the 4th quarter. Daiwa Securities Group Inc. now owns 2,929,265 shares of the real estate investment trust’s stock valued at $80,672,000 after acquiring an additional 2,909,745 shares during the last quarter. Institutional investors own 67.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Omega Healthcare Investors (OHI) Lifted to Outperform at Wells Fargo & Co” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.chaffeybreeze.com/2018/02/15/omega-healthcare-investors-ohi-lifted-to-outperform-at-wells-fargo-co.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply